Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance

Cell Death Differ. 2022 Feb;29(2):381-392. doi: 10.1038/s41418-021-00862-4. Epub 2021 Aug 31.

Abstract

The F-box and WD-repeat-containing protein 2 (FBXW2) plays a crucial role as an E3 ligase in regulating tumorigenesis. However, the functions of FBXW2 in breast cancer are still unknown. Here, we find that nuclear factor-kB (NF-κB) p65 is a new substrate of FBXW2. FBXW2 directly binds to p65, leading to its ubiquitination and degradation. Interestingly, p300 acetylation of p65 blocks FBXW2 induced p65 ubiquitination. FBXW2-p65 axis is a crucial regulator of SOX2-induced stemness in breast cancer. Moreover, FBXW2 inhibits breast tumor growth by regulating p65 degradation in vitro and in vivo. FBXW2 overexpression abrogates the effects of p65 on paclitaxel resistance in vitro and in vivo. Furthermore, FBXW2 induced p65 degradation is also confirmed in FBXW2-knockout mice. Our results identify FBXW2 as an important E3 ligase for p65 degradation, which provide insights into the tumor suppressor functions of FBXW2 in breast cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / genetics
  • Cell Transformation, Neoplastic
  • F-Box Proteins* / genetics
  • F-Box Proteins* / metabolism
  • Female
  • Humans
  • Mice
  • NF-kappa B / metabolism
  • Paclitaxel / pharmacology
  • Paclitaxel / therapeutic use
  • Transcription Factor RelA / metabolism*
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism
  • Ubiquitination

Substances

  • F-Box Proteins
  • FBXW2 protein, human
  • Fbxw2 protein, mouse
  • NF-kappa B
  • Rela protein, mouse
  • Transcription Factor RelA
  • Ubiquitin-Protein Ligases
  • Paclitaxel